Trial · NCT01042366
Adverse events37
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 37
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Hemoglobin | Blood and lymphatic system disorders | All Participants (Overall Study) | 4 | 15 | |
| other | Platelets | Investigations | All Participants (Overall Study) | 1 | 15 | |
| other | Edema | General disorders | All Participants (Overall Study) | 1 | 15 | |
| other | Fatigue (lethargy, malaise, asthenia) | General disorders | All Participants (Overall Study) | 4 | 15 | |
| other | Constitutional Symptoms-Other | General disorders | All Participants (Overall Study) | 3 | 15 | |
| other | Fever (in the absence of neutropenia, where neutropenia is defined as AGC<1.0 x 10e9/L) | General disorders | All Participants (Overall Study) | 1 | 15 | |
| other | Flushing | Vascular disorders | All Participants (Overall Study) | 1 | 15 | |
| other | Injection site reaction | General disorders | All Participants (Overall Study) | 5 | 15 | |
| other | Dermatology/Skin-Other | Skin and subcutaneous tissue disorders | All Participants (Overall Study) | 1 | 15 | |
| other | Alopecia | Skin and subcutaneous tissue disorders | All Participants (Overall Study) | 1 | 15 | |
| other | Anorexia | Metabolism and nutrition disorders | All Participants (Overall Study) | 1 | 15 | |
| other | Diarrhea patients without colostomy | Gastrointestinal disorders | All Participants (Overall Study) | 1 | 15 | |
| other | Dyspepsia/heartburn | Gastrointestinal disorders | All Participants (Overall Study) | 2 | 15 | |
| other | Nausea | Gastrointestinal disorders | All Participants (Overall Study) | 3 | 15 | |
| other | Taste disturbance (dysgeusia) | Gastrointestinal disorders | All Participants (Overall Study) | 1 | 15 | |
| other | Gastrointestinal-Other | Gastrointestinal disorders | All Participants (Overall Study) | 1 | 15 | |
| other | Dysphagia, esophagitis, odynophagia (painful swallowing) | Gastrointestinal disorders | All Participants (Overall Study) | 1 | 15 | |
| other | SGPT (ALT) (serum glutamic pyruvic transaminase) | Investigations | All Participants (Overall Study) | 1 | 15 | |
| other | Hepatic-Other | Hepatobiliary disorders | All Participants (Overall Study) | 2 | 15 | |
| other | Alkaline phosphatase | Investigations | All Participants (Overall Study) | 1 | 15 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01042366/events